| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $269.7M | $318.8M | $383.7M |
| YoY Revenue Growth % | -15.4% | -16.9% | — |
| Gross Profit | $125.0M | $158.8M | — |
| Gross Margin % | 46.4% | 49.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$31.9M | -$28.8M | $11.6M |
| Operating Margin % | -11.8% | -9.0% | 3.0% |
| Net Income (GAAP) | -$47.8M | -$62.2M | $7.8M |
| EBITDA (Normalized) | -$29.3M | -$20.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$10.0M | -$14.1M | $48.0M |
| Capital Expenditures (CapEx) | $3.3M | $10.4M | — |
| Free Cash Flow (FCF) | -$13.3M | -$24.5M | $48.0M |
| FCF Margin % | -4.9% | -7.7% | 12.5% |
| Return on Invested Capital (ROIC %) | -22.3% | -15.1% | — |
| Cash & Short-Term Equivalents | $18.5M | $28.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $131.6M | $179.0M | — |